One novel approach to identify potential biomarkers is to utilize liquid biopsy techniques in analyses of circulating tumor DNA and cells to measure the gene expression of PSMA, androgen receptors and their variants or neuroendocrine differentiation [33,34]. Here, FOLH1 is linked to neoplasm.